固体瘤细胞疗法 - 毒性管理原则
M Julve1, Y N S Wong2, K H J Lim3,4
1Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK.
Immuno-oncology technology
|April 16, 2025
概括
像lifileucel和afami-cel这样的采用细胞疗法 (ACT) 已被批准用于固体瘤. 本综述概述了管理与这些先进细胞疗法相关的独特毒性的主要原则.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
背景情况:
- 最近FDA批准了lifileucel和afami-cel用于晚期黑色素瘤和突肉瘤,这凸显了在固体瘤中采用细胞疗法 (ACT) 的日益使用.
- 随着这些先进疗法药品的日益普及,需要全面了解它们的相关毒性.
- 第一代瘤透淋巴细胞 (TIL) 疗法具有独特的毒性,与CAR T和TCR T等基因改造T细胞疗法不同,为临床医生带来了新的挑战.
研究的目的:
- 提供关于管理与实体瘤ACT相关的毒性方面的指导.
- 在新兴ACT的背景下讨论毒性管理的核心原则.
- 为医疗保健专业人员准备在固体瘤治疗中越来越多地使用ACT.
主要方法:
- 从血液性恶性瘤中化学抗原受体T细胞 (CAR T) 治疗的经验推断.
- 在固体瘤治疗方案中对高剂量互白素-2的历史使用情况的审查.
- 分析最近来自liffileucel和afami-cel批准和管理的数据.
主要成果:
- 在固体瘤中开发用于管理ACT相关毒性的核心原则.
- 与其他ACT相比,确定TIL疗法的独特毒性概况.
- 为管理这些新型治疗的医疗保健专业人员建立一个基金会.
结论:
- 有效的毒性管理对于在固体瘤中成功实施ACT至关重要.
- 对于医疗保健专业人员来说,在这个快速发展的领域中,对毒性管理原则的基础知识至关重要.
- 继续开发和理解ACT将改善患者在固体瘤治疗中的结果.
相关概念视频
01:27Tumor Immunotherapy
404
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
404
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K